MANAGEMENT OF ENDOCRINE DISEASE: Personalized medicine in the treatment of acromegaly
出版年份 2018 全文链接
标题
MANAGEMENT OF ENDOCRINE DISEASE: Personalized medicine in the treatment of acromegaly
作者
关键词
-
出版物
EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume 178, Issue 3, Pages R89-R100
出版商
Bioscientifica
发表日期
2018-01-17
DOI
10.1530/eje-17-1006
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- What is precision medicine?
- (2017) Inke R. König et al. EUROPEAN RESPIRATORY JOURNAL
- In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas
- (2017) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial
- (2017) Ian E Krop et al. LANCET ONCOLOGY
- Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis
- (2017) Vanessa Briceno et al. NEUROLOGICAL RESEARCH
- Long-Term Endocrine Outcomes Following Endoscopic Endonasal Transsphenoidal Surgery for Acromegaly and Associated Prognostic Factors
- (2017) Harish Babu et al. NEUROSURGERY
- Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly
- (2016) Federico Gatto et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pasireotide for the treatment of acromegaly
- (2016) Luiz Eduardo Wildemberg et al. EXPERT OPINION ON PHARMACOTHERAPY
- The Mexican Acromegaly Registry: Clinical and Biochemical Characteristics at Diagnosis and Therapeutic Outcomes
- (2016) Lesly A. Portocarrero-Ortiz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant
- (2016) Sanne E. Franck et al. NEUROENDOCRINOLOGY
- Predictive value of T2 relative signal intensity for response to somatostatin analogs in newly diagnosed acromegaly
- (2016) Ming Shen et al. NEURORADIOLOGY
- Experience with pegvisomant treatment in acromegaly in a single Brazilian tertiary reference center: efficacy, safety and predictors of response
- (2016) Leandro Kasuki et al. Archives of Endocrinology Metabolism
- A paradigm shift in the medical treatment of acromegaly: from a ‘trial and error’ to a personalized therapeutic decision-making process
- (2015) Mônica R. Gadelha CLINICAL ENDOCRINOLOGY
- Outcomes of Endoscopic Transsphenoidal Pituitary Surgery
- (2015) Robert F. Dallapiazza et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Failure to achieve disease control in acromegaly: cause analysis by a registry-based survey
- (2015) C. Schofl et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3
- (2015) S E Franck et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study
- (2015) Donato Iacovazzo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Treatment Outcome Results from the Bulgarian Acromegaly Database: Adjuvant Dopamine Agonist Therapy is Efficient in Less than One Fifth of Non-irradiated Patients
- (2015) S. Vandeva et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification
- (2015) Alexander S. G. Micko et al. JOURNAL OF NEUROSURGERY
- Endoscopic versus microscopic approach for surgical treatment of acromegaly
- (2015) Hussein Fathalla et al. NEUROSURGICAL REVIEW
- Precision Medicine — Personalized, Problematic, and Promising
- (2015) J. Larry Jameson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prediction of therapy response in acromegalic patients under pegvisomant therapy within the German ACROSTUDY cohort
- (2015) Caroline Sievers et al. Pituitary
- Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
- (2015) Annamaria Colao et al. Pituitary
- Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas
- (2015) Judit Dénes et al. PLoS One
- Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays
- (2014) Sauradeep Sarkar et al. ACTA NEUROCHIRURGICA
- Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly
- (2014) S. J. C. M. M. Neggers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expert consensus document: A consensus on the medical treatment of acromegaly
- (2014) Andrea Giustina et al. Nature Reviews Endocrinology
- Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
- (2014) Mônica R Gadelha et al. Lancet Diabetes & Endocrinology
- Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations
- (2013) Marie-Lise Jaffrain-Rea et al. ENDOCRINE-RELATED CANCER
- Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naïve patients with somatotroph adenomas
- (2013) Sarah Larkin et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Ki-67 is a predictor of acromegaly control with octreotide LAR independent of SSTR2 status and relates to cytokeratin pattern
- (2013) Leandro Kasuki et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas
- (2013) Bernhard Mayr et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies
- (2013) Laura Chinezu et al. HUMAN PATHOLOGY
- Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
- (2013) Robert R. Henry et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide
- (2013) Olivera Casar-Borota et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Endoscopic vs Microsurgical Transsphenoidal Surgery for Acromegaly: Outcomes in a Concurrent Series of Patients Using Modern Criteria For Remission
- (2013) Robert M. Starke et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria
- (2013) Derya Burcu Hazer et al. JOURNAL OF NEUROSURGERY
- Transsphenoidal Surgery for Growth Hormone–Secreting Pituitary Adenomas in 130 Patients
- (2013) Manouchehr Shirvani et al. World Neurosurgery
- AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression
- (2012) Leandro Kasuki et al. ENDOCRINE-RELATED CANCER
- Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)
- (2012) ALESSANDRO ALLEGRA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Altered MicroRNA Expression Profile in Human Pituitary GH Adenomas: Down-Regulation of miRNA Targeting HMGA1, HMGA2, and E2F1
- (2012) Daniela D'Angelo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway
- (2012) Harvinder S. Chahal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY
- (2012) A. J. van der Lely et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly
- (2012) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging
- (2012) Christa C. van Bunderen et al. Pituitary
- Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience
- (2012) Jessica Brzana et al. Pituitary
- Novel pathway for somatostatin analogs in patients with acromegaly
- (2012) Mônica R. Gadelha et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Familial isolated pituitary adenomas experience at a single center: clinical importance of AIP mutation screening
- (2011) Leandro Kasuki Jomori de Pinho et al. Arquivos Brasileiros de Endocrinologia e Metabologia
- Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly
- (2011) Stine Lyngvi Fougner et al. CLINICAL ENDOCRINOLOGY
- Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly
- (2011) Ansgar Heck et al. CLINICAL ENDOCRINOLOGY
- Resistance to Somatostatin Analogs in Acromegaly
- (2011) Annamaria Colao et al. ENDOCRINE REVIEWS
- Place of Cabergoline in Acromegaly: A Meta-Analysis
- (2011) Laure Sandret et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Endoscopic Transsphenoidal Surgery for Acromegaly: Remission Using Modern Criteria, Complications, and Predictors of Outcome
- (2011) John A. Jane et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Growth Hormone Receptor Variants and Response to Pegvisomant in Monotherapy or in Combination with Somatostatin Analogs in Acromegalic Patients: A Multicenter Study
- (2011) M. Filopanti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- AIPMutation in Pituitary Adenomas in the 18th Century and Today
- (2011) Harvinder S. Chahal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential expression of microRNAs in GH-secreting pituitary adenomas
- (2010) Zhi-Gang Mao et al. Diagnostic Pathology
- Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families
- (2010) Susana Igreja et al. HUMAN MUTATION
- Magnetic Resonance Imaging as a Predictor of Response to Somatostatin Analogs in Acromegaly after Surgical Failure
- (2010) Manel Puig-Domingo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study
- (2010) Adrian F. Daly et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Expression of E-Cadherin in Somatotroph Pituitary Adenomas Is Related to Tumor Size, Invasiveness, and Somatostatin Analog Response
- (2010) Stine Lyngvi Fougner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Short- and Long-Term Efficacy of Combined Cabergoline and Octreotide Treatment in Controlling IGF-I Levels in Acromegaly
- (2010) Priscilla Mattar et al. NEUROENDOCRINOLOGY
- Low Aryl Hydrocarbon Receptor-Interacting Protein Expression Is a Better Marker of Invasiveness in Somatotropinomas than Ki-67 and p53
- (2010) Leandro Kasuki Jomori de Pinho et al. NEUROENDOCRINOLOGY
- Role of the addition of cabergoline to the management of acromegalic patients resistant to longterm treatment with octreotide LAR
- (2010) Lucio Vilar et al. Pituitary
- Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications
- (2009) Marie-Lise Jaffrain-Rea et al. ENDOCRINE-RELATED CANCER
- Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy
- (2009) Mónica Marazuela et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly
- (2009) Marily Theodoropoulou et al. INTERNATIONAL JOURNAL OF CANCER
- Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly
- (2009) Leonardo Vieira Neto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification and Characterization of Two Novel Truncated but Functional Isoforms of the Somatostatin Receptor Subtype 5 Differentially Present in Pituitary Tumors
- (2009) Mario Durán-Prado et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly
- (2009) Ignacio Bernabeu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Octreotide LARvs.surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study
- (2008) Annamaria Colao et al. CLINICAL ENDOCRINOLOGY
- Acromegaly
- (2008) Anat Ben-Shlomo et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
- (2008) I M Holdaway et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Clinical use of cabergoline as primary and adjunctive treatment for acromegaly
- (2008) V J Moyes et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR
- (2008) Giselle F Taboada et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Correlation ofin Vitroandin VivoSomatotropic Adenoma Responsiveness to Somatostatin Analogs and Dopamine Agonists with Immunohistochemical Evaluation of Somatostatin and Dopamine Receptors and Electron Microscopy
- (2008) Diego Ferone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Low Levels of Raf Kinase Inhibitory Protein in Growth Hormone-Secreting Pituitary Adenomas Correlate with Poor Response to Octreotide Treatment
- (2008) Stine Lyngvi Fougner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly
- (2008) Antonio Bianchi et al. Pituitary
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now